Skip to main content
Clinical Trials/NCT00394225
NCT00394225
Completed
Not Applicable

The Effects of Helium-Hyperoxia on 6-Minute Walking Distance in Chronic Obstructive Pulmonary Disease - A Randomized, Controlled Trial

University of Saskatchewan1 site in 1 country16 target enrollmentJuly 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
University of Saskatchewan
Enrollment
16
Locations
1
Primary Endpoint
6 minute walking distance
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

We assessed the effect of altering inspired gas on the 6MWT distance in COPD. We hypothesized that HeO2 would improve walking distance and reduce shortness of breath compared to both RA and O2, and potentially improve quality of life for COPD patients.

Detailed Description

We hypothesized that inspiring helium-hyperoxia (HeO2) would significantly improve 6-minute walking test (6MWT) distance in Chronic Obstructive Pulmonary Disease (COPD) subjects. This was a blinded, randomized crossover study. At Visit 1 we assessed pulmonary function, exercise capacity and 6MWT distance. Visits 2 and 3 consisted of four 6MWT with different inspired gases: room air by mask (RA), 100% O2 by mask (Mask O2), 100% O2 by nasal prongs (Nasal O2), and 70% He/30% O2 by mask (HeO2). Walking distance, shortness of breath, leg fatigue, O2 saturation and heart rate (HR) were assessed

Registry
clinicaltrials.gov
Start Date
July 2005
End Date
May 2006
Last Updated
19 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Exertional dyspnea
  • Activity limitation

Exclusion Criteria

  • Recent exacerbation (\< 4 wks)
  • Supplemental O2
  • Significant cardiovascular/musculoskeletal abnormalities

Outcomes

Primary Outcomes

6 minute walking distance

Secondary Outcomes

  • shortness of breath
  • leg fatigue
  • arterial oxygen saturation

Study Sites (1)

Loading locations...

Similar Trials